59.00
Bio Techne Corp (TECH) 最新ニュース
Bio-Techne Corp $TECH Shares Sold by JPMorgan Chase & Co. - MarketBeat
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Bio-Techne Corporation (TECH) Carries Attractive FY27 Organic Growth Projections - Finviz
Bio-Techne to Present at Upcoming Investor Conferences - Finviz
RSI Alert: Bio-Techne (TECH) Now Oversold - Nasdaq
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know - Yahoo Finance
Bio-Techne Corp $TECH Holdings Trimmed by Granite Investment Partners LLC - MarketBeat
OneDigital Investment Advisors LLC Takes Position in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (NASDAQ:TECH) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Aberdeen Group plc Has $499,000 Holdings in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp $TECH Shares Sold by Vanguard Group Inc. - MarketBeat
Bio-Techne Corp $TECH Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A. - MarketBeat
17,441 Shares in Bio-Techne Corp $TECH Acquired by Maridea Wealth Management LLC - MarketBeat
Evaluating Bio-Techne (TECH) After Ella’s CE-IVD Milestone And Diagnostics Growth Prospects - Yahoo Finance
Bio-Techne (TECH) Gains CE-IVD Certification for Ella Platform i - GuruFocus
Bio-Techne’s Ella platform achieves CE-IVD marking, available for sale in E.U. - TipRanks
Bio-Techne's Ella Immunoassay Platform Receives CE-IVD Marking In EU - Nasdaq
Bio-Techne Corp (TECH): Investor Outlook Highlights 25.56% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge?Based Immunoassays for European Clinical Laboratories - Investing News Network
Bio-Techne Corp's Ella platform receives CE-IVD marking, available for sale in EU - marketscreener.com
Bio-Techne Corp's Ella Platform Receives CE-Ivd Marking, Available For Sale In EU - TradingView
Fast biomarker test platform gets EU CE-IVD mark for hospital labs - Stock Titan
A | Is Bio Techne Corporation showing insider buyingWeekly Stock Report & Smart Money Movement Tracker - mfd.ru
Why Bio Techne Corporation stock is trending among retail tradersTake Profit & Real-Time Buy Signal Notifications - mfd.ru
ING Groep NV Acquires Shares of 20,266 Bio-Techne Corp $TECH - MarketBeat
Caprock Group LLC Takes $1.71 Million Position in Bio-Techne Corp $TECH - MarketBeat
Principal Financial Group Inc. Sells 35,059 Shares of Bio-Techne Corp $TECH - MarketBeat
Is Bio Techne Corporation (TE1) stock expanding market penetrationJuly 2025 Earnings & Weekly High Potential Alerts - mfd.ru
(TECH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
5 Insightful Analyst Questions From Bio-Techne's Q4 Earnings Call - Finviz
There May Be Reason For Hope In Bio-Techne's (NASDAQ:TECH) Disappointing Earnings - Yahoo Finance
What Are Wall Street Analysts' Target Price for Bio-Techne Stock? - Barchart.com
Bio-Techne Announces Changes to its Leadership Team - Investing News Network
Ex-Dividend Reminder: Bio-Techne, 3M and Eli Lilly - Nasdaq
Madison Asset Management LLC Acquires Shares of 744,651 Bio-Techne Corp $TECH - MarketBeat
Bio-Techne (NASDAQ:TECH) Stock Rating Upgraded by Zacks Research - MarketBeat
Bio-Techne Corp (NASDAQ:TECH) Passes Key Quality Investing Screen - ChartMill
Baader Bank Aktiengesellschaft Buys 38,082 Shares of Bio-Techne Corp $TECH - MarketBeat
Azzad Asset Management Inc. ADV Has $774,000 Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
How Flat Sales, Higher EPS, and New Organoid Tools At Bio-Techne (TECH) Have Changed Its Investment Story - Yahoo Finance
Bio-Techne stock price target raised to $65 from $60 at Stifel By Investing.com - Investing.com Nigeria
New York State Common Retirement Fund Sells 465,634 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne stock price target raised to $65 from $60 at Stifel - Investing.com UK
Wells Fargo & Company Issues Positive Forecast for Bio-Techne (NASDAQ:TECH) Stock Price - MarketBeat
TECH Stock Update: Wells Fargo Raises Price Target for Bio-Techn - GuruFocus
Bio-Techne Earnings: Reasonable Growth Despite Lower Cell Therapy Demand - Morningstar
Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Cor - GuruFocus
Bio-Techne (TECH) Sees Target Price Raised by Stifel | TECH Stoc - GuruFocus
UBS Maintains Buy Rating on Bio-Techne (TECH) with Raised Price Target | TECH Stock News - GuruFocus
Citigroup Raises Price Target for Bio-Techne (TECH) to $80.00 | - GuruFocus
7 Analysts Assess Bio-Techne: What You Need To Know - Benzinga
Assessing Bio-Techne (TECH) Valuation After Earnings Beat And New Research Product Launches - simplywall.st
Tech Stock Update: Evercore ISI Group Raises Price Target for TE - GuruFocus
大文字化:
|
ボリューム (24 時間):